A 510(k) submission from GE HealthCare marks another step in the expansion of photon-counting CT technologies designed to capture richer spectral data and simplify scan acquisition.
Photon-counting CT is drawing attention as a possible next step in spectral imaging and material differentiation. As vendors advance new detector architectures and pursue regulatory clearance, radiology leaders are weighing how next-generation photon-counting systems could influence diagnostic workflows, reconstruction demands, and long-term data management.
Against this backdrop, GE HealthCare recently submitted a 510(k) to the US Food and Drug Administration for Photonova Spectra, a photon-counting CT with intended capabilities that include ultra-high-definition imaging, expanded material separation, and a one-scan workflow approach. Chad Rowland, executive director of premium CT and photon-counting CT at GE HealthCare, discusses the clinical limitations photon-counting CT is intended to address and how such systems could influence day-to-day CT operations.
From a clinical standpoint, what specific limitations of conventional CT does photon-counting technology aim to solve?
Photon-counting CT represents a transformative advancement in medical imaging. Unlike conventional CT systems that convert X-rays into light before measuring them, photon-counting CT directly counts individual X-ray photons and measures their energy. This enables the potential for higher spectral and spatial resolution and improved tissue characterization.
Photon-counting CT isn’t brand new conceptually. What advances in detector materials or engineering have recently made clinical adoption more feasible?
While the concept of photon-counting CT is not brand new, recent engineering advancements have sparked creative thinking and additional clinical consideration. Unlike conventional CT systems that convert X-rays into light before measuring them, photon-counting CT directly counts individual X-ray photons and measures their energy as they hit the CT detector, enabling the potential for higher spectral and spatial resolution and improved tissue characterization.
We designed our 510(k)-pending Photonova Spectra system (which is still under review and not cleared or available for sale in the US) with Deep Silicon, a novel detector material designed to bring enhanced spectral imaging.
How should radiologists think about photon-counting CT’s impact on routine imaging workflows?
The many potential applications of photon-counting CT technology bring about continued excitement in the industry. New detector technology, along with AI algorithms and imaging reconstruction techniques, may continue to push the frontiers of CT and promise innovations in the diagnostic and workflow process. Altogether, photon-counting technology has the potential to be a substantial step forward for CT imaging that may benefit millions of patients worldwide.
Our 510(k) pending device is designed to be user-friendly and aims to simplify the CT process with Effortless Workflow with universal full fidelity scan, which enables a one-scan approach to reduce exam-specific protocols and enable automated reconstruction of ultra-high-resolution spectral images on demand. With this design, the goal is for staff to be able to rely on one protocol setup for many exams, reducing complexity and supporting efficiency.
Which clinical areas stand to benefit most from photon-counting CT in its current generation?
Photon-counting CT technology has the potential to further improve the capabilities of traditional CT, including the visualization of minute details of organ structures, improved tissue characterization, accurate material density measurement (or quantification), and low radiation dose. Altogether, it has the promise of being a substantial step forward for CT imaging that can potentially benefit millions of patients worldwide.
The clinical potential of the 510(k)-pending Photonova Spectra spans a range of specialties, with the technology’s design seeking to unlock new levels of clarity, detail, and diagnostic confidence. The system’s clinical design goals include:
- Neurology: Visualization of tiny structures like the inner ear and clear differentiation between brain grey and white matter at the same time.
- Oncology: Clear lesion characterization and precise quantification due to the system’s Deep Silicon detectors. Its iodine mapping also aims to help clinicians distinguish oncological findings and support treatment monitoring.
- Musculoskeletal imaging: Visualization of small fractures and bone marrow edema, supporting detailed assessments for orthopedic care.
- Thoracic imaging: Ultra-high-definition chest scans.
- Cardiology: The combination of spatial and spectral imaging in one scan with the goal of enabling in-stent lumen assessment, plaque characterization, and myocardial assessment.
Photon-counting CT promises vastly more data per scan. What are the practical implications for PACS, radiologist reading times, and long-term enterprise storage?
Photon-counting CT detectors can generate up to 50 times more raw data than conventional CT. Photonova Spectra is designed to harness this data with the help of NVIDIA’s accelerated computing technology to turn this data into DICOM images that can be utilized by radiologists.
Ultimately, an increased utilization of spectral imaging, high matrix sizes (1024×1024), and thinner slices can help increase the amount of data to load into the PACS and is an important consideration when planning a PCCT installation
As vendors pursue FDA clearance for photon-counting systems, what questions should imaging leaders ask to determine whether this technology is appropriate for their institution?
When evaluating new technologies, I’d recommend focusing on the potential benefits these solutions could provide to patients and clinicians. Specifically, how could it help enable patient care and fast, accurate decision-making? How could it improve workflow efficiencies, and what specific workflow challenges is it designed to address? How does this differ from our existing CT systems? How easily will it integrate with our existing solutions? Photon-counting CT represents a transformative advancement in medical imaging.
Photo caption: Photonova Spectra
Photo credit: GE HealthCare
Editor’s note: Responses have been lightly edited.
